185 related articles for article (PubMed ID: 20652256)
21. Human subthalamic nucleus: evaluation with high-resolution MR imaging at 3.0 T.
Kitajima M; Korogi Y; Kakeda S; Moriya J; Ohnari N; Sato T; Hayashida Y; Hirai T; Okuda T; Yamashita Y
Neuroradiology; 2008 Aug; 50(8):675-81. PubMed ID: 18443775
[TBL] [Abstract][Full Text] [Related]
22. Defining the Border of the Subthalamic Nucleus for Deep Brain Stimulation: A Proposed Model Using the Symmetrical Sigmoid Curve Function.
Chau AMT; Jacques A; Lind CR
World Neurosurg; 2020 Nov; 143():e567-e573. PubMed ID: 32791216
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
24. Characterization and correction of distortions in stereotactic magnetic resonance imaging for bilateral subthalamic stimulation in Parkinson disease.
Menuel C; Garnero L; Bardinet E; Poupon F; Phalippou D; Dormont D
J Neurosurg; 2005 Aug; 103(2):256-66. PubMed ID: 16175855
[TBL] [Abstract][Full Text] [Related]
25. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
[TBL] [Abstract][Full Text] [Related]
26. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
Tan ZG; Zhou Q; Huang T; Jiang Y
Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
[TBL] [Abstract][Full Text] [Related]
27. Placement of deep brain stimulators into the subthalamic nucleus or Globus pallidus internus: technical approach.
Starr PA
Stereotact Funct Neurosurg; 2002; 79(3-4):118-45. PubMed ID: 12890973
[TBL] [Abstract][Full Text] [Related]
28. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.
Okun MS; Fernandez HH; Wu SS; Kirsch-Darrow L; Bowers D; Bova F; Suelter M; Jacobson CE; Wang X; Gordon CW; Zeilman P; Romrell J; Martin P; Ward H; Rodriguez RL; Foote KD
Ann Neurol; 2009 May; 65(5):586-95. PubMed ID: 19288469
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional fluid-attenuated inversion recovery sequence for visualisation of subthalamic nucleus for deep brain stimulation in Parkinson's disease.
Heo YJ; Kim SJ; Kim HS; Choi CG; Jung SC; Lee JK; Lee CS; Chung SJ; Cho SH; Lee GR
Neuroradiology; 2015 Sep; 57(9):929-35. PubMed ID: 26156865
[TBL] [Abstract][Full Text] [Related]
30. [Discrepancy between imaging and neurophysiology in deep brain stimulation of medial pallidum and subthalamic nucleus in Parkinson's disease].
Guridi J; Rodríguez-Oroz MC; Ramos E; Linazasoro G; Obeso JA
Neurologia; 2002 Apr; 17(4):183-92. PubMed ID: 11940406
[TBL] [Abstract][Full Text] [Related]
31. Improved targeting of the globus pallidus interna using quantitative susceptibility mapping prior to MR-guided focused ultrasound ablation in Parkinson's disease.
Ebani EJ; Kaplitt MG; Wang Y; Nguyen TD; Askin G; Chazen JL
Clin Imaging; 2020 Dec; 68():94-98. PubMed ID: 32580108
[TBL] [Abstract][Full Text] [Related]
32. Precise targeting of the globus pallidus internus with quantitative susceptibility mapping for deep brain stimulation surgery.
Wei H; Zhang C; Wang T; He N; Li D; Zhang Y; Liu C; Yan F; Sun B
J Neurosurg; 2019 Oct; 133(5):1605-1611. PubMed ID: 31604332
[TBL] [Abstract][Full Text] [Related]
33. Electrode implantation for deep brain stimulation in dystonia: a fast spin-echo inversion-recovery sequence technique for direct stereotactic targeting of the GPI.
Pinsker MO; Volkmann J; Falk D; Herzog J; Alfke K; Steigerwald F; Deuschl G; Mehdorn M
Zentralbl Neurochir; 2008 May; 69(2):71-5. PubMed ID: 18444217
[TBL] [Abstract][Full Text] [Related]
34. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
[TBL] [Abstract][Full Text] [Related]
35. 1.5T versus 3T MRI for targeting subthalamic nucleus for deep brain stimulation.
Cheng CH; Huang HM; Lin HL; Chiou SM
Br J Neurosurg; 2014 Aug; 28(4):467-70. PubMed ID: 24191703
[TBL] [Abstract][Full Text] [Related]
36. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.
Burdick AP; Foote KD; Wu S; Bowers D; Zeilman P; Jacobson CE; Ward HE; Okun MS
Neuroimage; 2011 Jan; 54 Suppl 1():S227-32. PubMed ID: 20932923
[TBL] [Abstract][Full Text] [Related]
37. Quantitative Analysis for the Delineation of the Subthalamic Nuclei on Three-Dimensional Stereotactic MRI Before Deep Brain Stimulation Surgery for Medication-Refractory Parkinson's Disease.
Su CY; Wong AM; Chang CC; Tu PH; Chen CC; Yeh CH
Front Hum Neurosci; 2022; 16():829198. PubMed ID: 35273486
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the role of 1.5T quantitative susceptibility mapping for subthalamic nucleus targeting in deep brain stimulation surgery.
Rashid T; Hwang R; DiMarzio M; Hancu I; Pilitsis JG
J Neuroradiol; 2021 Feb; 48(1):37-42. PubMed ID: 31150663
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the Stereotactic Accuracies of Function-Guided Deep Brain Stimulation, Calculated Using Multitrack Target Locations Geometrically Inferred from Three-Dimensional Trajectory Rotations, and of Magnetic Resonance Imaging-Guided Deep Brain Stimulation and Outcomes.
Park SC; Lee CS; Kim SM; Choi EJ; Lee JK
World Neurosurg; 2017 Feb; 98():734-749.e7. PubMed ID: 27876666
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
